-
1
Safety assessment of ripretinib: a real-world adverse event analysis from the food and drug administration adverse event reporting system
Published 2025-03-01Subjects: Get full text
Article -
2
Real world pharmacovigilance study of antineoplastic drug related vitiligo risks
Published 2025-07-01Subjects: Get full text
Article -
3
Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system
Published 2025-01-01Subjects: Get full text
Article